Hao M. Sun

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Identification and characterization of MARCO-expressing tumor-associated macrophages in pancreatic ductal adenocarcinoma with pan-cancer relevance.

Identification and characterization of MARCO-expressing tumor-associated macrophages in pancreatic ductal adenocarcinoma with pan-cancer relevance.

Journal: NPJ precision oncology

Published: August 04, 2025

Global burden of head and neck cancer: Epidemiological transitions, inequities, and projections to 2050.

Global burden of head and neck cancer: Epidemiological transitions, inequities, and projections to 2050.

Journal: Frontiers in oncology

Published: July 13, 2025

Bispecific antibodies targeting CD20xCD3 in immunotherapy for adult B-cell lymphoma: insights from the 65th American Society of Hematology 2023 annual meeting.

Bispecific antibodies targeting CD20xCD3 in immunotherapy for adult B-cell lymphoma: insights from the 65th American Society of Hematology 2023 annual meeting.

Journal: Expert opinion on biological therapy

Published: May 08, 2024

A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody.

A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody.

Journal: Scientific reports

Published: February 01, 2024

Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing Lung Adenocarcinoma and Benign Pulmonary Nodules.

Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing Lung Adenocarcinoma and Benign Pulmonary Nodules.

Journal: Journal of proteome research

Published: December 12, 2023

Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation.

Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation.

Journal: Cancer biology & therapy

Published: November 27, 2023

Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting.

Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting.

Journal: Expert opinion on biological therapy

Published: October 18, 2023

Novel Biomarker miRNA-625-3p Promotes Cell Proliferation and Metastasis of Lung Adenocarcinoma by Targeting KLF9.

Novel Biomarker miRNA-625-3p Promotes Cell Proliferation and Metastasis of Lung Adenocarcinoma by Targeting KLF9.

Journal: Anticancer research

Published: July 23, 2023

Correction: Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives.

Correction: Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives.

Journal: Biomarker research

Published: December 21, 2022

Abnormal phenotype of Nrf2 is associated with poor prognosis through hypoxic/VEGF-A-Rap1b/VEGFR2 pathway in gastric cancer.

Abnormal phenotype of Nrf2 is associated with poor prognosis through hypoxic/VEGF-A-Rap1b/VEGFR2 pathway in gastric cancer.

Journal: Aging

Published: November 11, 2020

Applications of gut microbiota in patients with hematopoietic stem-cell transplantation.

Applications of gut microbiota in patients with hematopoietic stem-cell transplantation.

Journal: Experimental hematology & oncology

Published: October 02, 2020

Efficacy and safety of domestic and brand name bortezomib in the treatment of newly diagnosed multiple myeloma

Efficacy and safety of domestic and brand name bortezomib in the treatment of newly diagnosed multiple myeloma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: April 22, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026